Decoding 340B: The $81 Billion Drug Discount Program Explained | The Elephant in the Dome

View Online FOR IMMEDIATE RELEASE [July 30, 2026] MEDIA CONTACT: Staff Contact Decoding 340B: The $81 Billion Drug Discount Program Explained | The Elephant in the Dome In this episode of The Elephant in the Dome, Senator Chris Gildon hosts Senator Ron Muzzall the ranking Republican on the Senate Health and Long-Term Care Committee. They break down the complex 340B Drug Pricing Program—a federal initiative designed to help safety-net health clinics and hospitals acquire discounted prescription medication for low-income patients. They discuss how the program expanded from $12 billion to $81 billion, the balance between supporting struggling community hospitals and keeping private insurance costs manageable, and the legal battle surrounding Senate Bill 5981. TRANSCRIPT Washington State Legislature | Official Legislative Email Bulletin You are receiving this update because you subscribed to email communications from this legislative office. To manage your topic subscriptions or update your subscriber profile, visit GovDelivery.